Heart failure in mice induces a dysfunction of the sinus node associated with reduced CaMKII signaling.


Journal

The Journal of general physiology
ISSN: 1540-7748
Titre abrégé: J Gen Physiol
Pays: United States
ID NLM: 2985110R

Informations de publication

Date de publication:
05 09 2022
Historique:
received: 09 02 2021
accepted: 18 03 2022
entrez: 22 4 2022
pubmed: 23 4 2022
medline: 27 4 2022
Statut: ppublish

Résumé

Dysfunction of the sinoatrial node (SAN), the natural heart pacemaker, is common in heart failure (HF) patients. SAN spontaneous activity relies on various ion currents in the plasma membrane (voltage clock), but intracellular Ca2+ ([Ca2+]i) release via ryanodine receptor 2 (RYR2; Ca2+ clock) plays an important synergetic role. Whereas remodeling of voltage-clock components has been revealed in HF, less is known about possible alterations to the Ca2+ clock. Here, we analyzed [Ca2+]i handling in SAN from a mouse HF model after transverse aortic constriction (TAC) and compared it with sham-operated animals. ECG data from awake animals showed slower heart rate in HF mice upon autonomic nervous system blockade, indicating intrinsic sinus node dysfunction. Confocal microscopy analyses of SAN cells within whole tissue showed slower and less frequent [Ca2+]i transients in HF. This correlated with fewer and smaller spontaneous Ca2+ sparks in HF SAN cells, which associated with lower RYR2 protein expression level and reduced phosphorylation at the CaMKII site. Moreover, PLB phosphorylation at the CaMKII site was also decreased in HF, which could lead to reduced sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) function and lower sarcoplasmic reticulum Ca2+ content, further depressing the Ca2+ clock. The inhibition of CaMKII with KN93 slowed [Ca2+]i transient rate in both groups, but this effect was smaller in HF SAN, consistent with less CaMKII activation. In conclusion, our data uncover that the mechanism of intrinsic pacemaker dysfunction in HF involves reduced CaMKII activation.

Identifiants

pubmed: 35452507
pii: 213178
doi: 10.1085/jgp.202112895
pmc: PMC9040062
pii:
doi:

Substances chimiques

Ryanodine Receptor Calcium Release Channel 0
Calcium-Calmodulin-Dependent Protein Kinase Type 2 EC 2.7.11.17
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Chinese Scholarship Council
Organisme : PHC Maimonide
Organisme : Institut National de la Santé et de la Recherche Médicale
Organisme : NHLBI NIH HHS
ID : R01 HL055438
Pays : United States
Organisme : Israel Ministry of Science
Organisme : Agence National de la Recherche
ID : ANR-19-CE-0031-01

Informations de copyright

© 2022 Xue et al.

Références

Circulation. 2003 Aug 12;108(6):760-6
pubmed: 12885752
Int J Cardiol Heart Vasc. 2016 Mar 16;11:24-28
pubmed: 28616522
J Mol Cell Cardiol. 2009 Aug;47(2):157-70
pubmed: 19361514
JACC Heart Fail. 2013 Jun;1(3):259-66
pubmed: 24621878
Am J Cardiol. 1983 Jan 1;51(1):52-60
pubmed: 6849267
JCI Insight. 2017 Apr 20;2(8):
pubmed: 28422759
Circulation. 2004 Apr 20;109(15):1898-903
pubmed: 15037529
Circ Res. 2010 Mar 5;106(4):659-73
pubmed: 20203315
Cardiovasc Res. 2005 Jun 1;66(3):472-81
pubmed: 15914112
Circulation. 2004 Aug 24;110(8):897-903
pubmed: 15302799
Pflugers Arch. 2007 Jun;454(3):451-9
pubmed: 17273863
J Mol Cell Cardiol. 2007 Sep;43(3):281-91
pubmed: 17643448
Front Physiol. 2015 Feb 13;6:28
pubmed: 25741284
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H532-44
pubmed: 27402669
Nat Med. 2005 Apr;11(4):409-17
pubmed: 15793582
Circ Res. 2021 Jul 23;129(3):e35-e52
pubmed: 34111951
Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H352-60
pubmed: 18487442
Science. 1997 May 2;276(5313):800-6
pubmed: 9115206
Circulation. 1997 Jul 1;96(1):260-6
pubmed: 9236443
Sci Rep. 2020 Jul 9;10(1):11279
pubmed: 32647133
Front Physiol. 2016 Jun 02;7:197
pubmed: 27313537
Cardiovasc Res. 2013 May 1;98(2):204-15
pubmed: 23393229
Int J Mol Sci. 2019 Jun 30;20(13):
pubmed: 31262061
Circ Res. 2013 Aug 30;113(6):690-708
pubmed: 23989713
Cardiovasc Res. 2004 Feb 1;61(2):208-17
pubmed: 14736537
Circulation. 1993 Dec;88(6):2953-61
pubmed: 8252708
J Cardiopulm Rehabil. 2006 Mar-Apr;26(2):86-9
pubmed: 16569976
Circ Res. 2006 Jan 6;98(1):15-24
pubmed: 16397154
J Vis Exp. 2011 Nov 21;(57):
pubmed: 22126906
Circ Res. 2000 Oct 27;87(9):760-7
pubmed: 11055979
Heart Fail Rev. 2000 Jun;5(2):167-73
pubmed: 16228142
Circ Heart Fail. 2018 Aug;11(8):e004969
pubmed: 30354566
J Clin Invest. 1969 Nov;48(11):2019-31
pubmed: 5398888
Circulation. 2000 Jun 27;101(25):2975-80
pubmed: 10869272
Cardiovasc Res. 1974 Mar;8(2):153-61
pubmed: 4207176
J Pharmacol Sci. 2006;100(5):338-69
pubmed: 16799255
J Am Coll Cardiol. 1997 Dec;30(7):1589-97
pubmed: 9385881
J Mol Cell Cardiol. 2011 Oct;51(4):468-73
pubmed: 21276796
Expert Opin Biol Ther. 2010 Jan;10(1):29-41
pubmed: 20078230
Exp Ther Med. 2017 Feb;13(2):771-779
pubmed: 28352365
J Am Coll Cardiol. 2019 May 7;73(17):2209-2225
pubmed: 31047010
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5972-7
pubmed: 19276108
Sci Rep. 2020 Jun 19;10(1):9971
pubmed: 32561798
Front Physiol. 2018 Oct 04;9:1390
pubmed: 30337883
Front Pharmacol. 2014 Mar 18;5:48
pubmed: 24672485
Circ Res. 2001 Jun 22;88(12):1254-8
pubmed: 11420301
Circulation. 1989 Dec;80(6):1675-80
pubmed: 2598430
Dev Biol. 2013 Jan 1;373(1):149-62
pubmed: 23085412
Pflugers Arch. 2002 Sep;444(6):801-9
pubmed: 12355181
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1805-11
pubmed: 20889842
Circulation. 1982 Jun;65(6):1213-23
pubmed: 6804111
Circulation. 2007 Apr 10;115(14):1921-32
pubmed: 17420362
Cardiovasc Res. 1970 Apr;4(2):160-7
pubmed: 4192616
Front Physiol. 2015 Feb 02;6:18
pubmed: 25698973
Am J Cardiol. 2001 Mar 1;87(5):655-7, A10-1
pubmed: 11230859
J Mol Cell Cardiol. 2013 Sep;62:80-9
pubmed: 23651631
J Am Heart Assoc. 2013 May 24;2(3):e000150
pubmed: 23709563
Circ Res. 2017 Jul 7;121(2):181-195
pubmed: 28684623
Eur J Heart Fail. 2005 Aug;7(5):739-47
pubmed: 16087130
Circ Res. 2012 Jun 8;110(12):1661-77
pubmed: 22679140
Eur J Biochem. 1996 Sep 1;240(2):408-15
pubmed: 8841406
J Mol Cell Cardiol. 2010 Jul;49(1):25-32
pubmed: 20353795

Auteurs

Jian-Bin Xue (JB)

Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.

Almudena Val-Blasco (A)

Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.

Moran Davoodi (M)

Biomedical Engineering, Technion Institute, Haifa, Israel.

Susana Gómez (S)

Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.

Yael Yaniv (Y)

Biomedical Engineering, Technion Institute, Haifa, Israel.

Jean-Pierre Benitah (JP)

Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.

Ana María Gómez (AM)

Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH